All articles by Clinical Trials Arena Team

Pipeline Moves: Pfizer’s flu vaccine approval chances rise after Phase III completion

This week on Pipeline Moves, we kick off by looking at a Phase III trial completion of Pfizer’s influenza vaccine…
Pipeline Moves: Progression prospects for stuttering candidate increase after trial completion

This week on Pipeline Moves, we kick off by looking at a Phase II trial of Noema Pharma’s NOE-105 in…
Pipeline moves: Approval prospects for SBS candidate rise after Phase III trial meets endpoints

This week on Pipeline Moves, we kick off by looking at success of a Phase III trial of Ironwood Pharmaceuticals’…
Pipeline moves: Prospects drop after investigator-led trial of Roche’s Tecentriq terminated

This week on Pipeline Moves, we kick off by looking at the termination of a Phase II investigator-led trial of…
Pipeline Moves: Approval prospects for ALL candidate rise after Phase III completion

This week on Pipeline Moves, we kick off by looking at the completion of a Phase III investigator-led trial of…

Pipeline Moves: Approval prospects for Roche’s tiragolumab rise in oesophageal squamous cell carcinoma

This week on Pipeline Moves, we kick off by looking at a Phase III trial by Roche in its oesophageal…
Pipeline Moves: Approval chances for thalassaemia candidate rise after Phase III trial meets endpoints.

This week on Pipeline Moves, we kick off by looking at a Phase III trial in alpha thalassaemia and beta…
Pipeline Moves: Phase III bronchiectasis trial terminated due to recruitment issues

This week on Pipeline Moves, we kick off by looking at the termination of a Phase III trial in non-cystic…
Pipeline Moves: Phase transition rate improves for RMS candidate after Phase II/III success

This week on Pipeline Moves, we kick off by looking at the completion of a Phase II/III trial for relapsing…
Pipeline Moves: Approval prospects rise for Mirum’s rare disease candidate after trial completion

This week on Pipeline Moves, we kick off by looking at the completion of a Phase III trial for cerebrotendinous…